Chemistry:GM-2505

From HandWiki

GM-2505 is an experimental psychedelic antidepressant that works as a 5-HT2A receptor agonist. Compared to other 5-HT2A receptor agonists, it has a shorter duration of action.[1][2]

References

  1. ↑ Hughes, Zoe; Klein, Adam; Dvorak, Dino; Austin, Eric; Kiss, Laszlo; Marek, Gerard; Sporn, Jonathan; Kruegel, Andrew (May 2023). "22. GM-2505 has Rapid Onset Antidepressant Activity and Causes Dose-Dependent Changes in qEEG With Increasing 5-HT2A Receptor Occupancy". Biological Psychiatry 93 (9): S102–S103. doi:10.1016/j.biopsych.2023.02.262. 
  2. ↑ Beaney, Abigail (6 December 2023). "Gilgamesh to initiate Phase IIa trial of fast-acting psychedelic drug". Clinical Trials Arena. https://www.clinicaltrialsarena.com/news/gilgamesh-phaseiia-psychedelic-drug-trial/?cf-view. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:GM-2505&oldid=3323775"